Search Results

By JOYCE KURISKO, MBA; TIM BARTHOLOW, MD; and SCOTT LITOW, ASA  / December 10, 2022

Cancer Drugs and Price Controls: Is It Time?

According to a recent article published in Cancer Epidemiology, Biomarkers & Prevention, cancer care in the United States exceeded $208 billion in 2020 and is expected to surpass $240 billion by 2030.1 These estimates are driven largely by a growing and aging population. The expenditures...